Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$74.43 - $92.22 $699,642 - $866,868
9,400 Added 254.05%
13,100 $1.08 Million
Q3 2023

Nov 14, 2023

SELL
$85.07 - $94.48 $159,165 - $176,772
-1,871 Reduced 33.58%
3,700 $327,000
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $162,178 - $187,661
1,871 Added 50.57%
5,571 $482,000
Q1 2023

May 15, 2023

SELL
$87.74 - $117.27 $4.04 Million - $5.4 Million
-46,030 Reduced 92.56%
3,700 $359,000
Q4 2022

Feb 14, 2023

SELL
$80.93 - $108.63 $186,139 - $249,849
-2,300 Reduced 4.42%
49,730 $5.15 Million
Q3 2022

Nov 14, 2022

SELL
$82.16 - $96.94 $2.46 Million - $2.91 Million
-30,000 Reduced 36.57%
52,030 $4.41 Million
Q2 2022

Aug 15, 2022

BUY
$71.48 - $86.85 $2.16 Million - $2.63 Million
30,230 Added 58.36%
82,030 $6.8 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $3.06 Million - $3.82 Million
41,200 Added 388.68%
51,800 $3.99 Million
Q2 2021

Aug 16, 2021

BUY
$75.51 - $84.79 $800,406 - $898,774
10,600 New
10,600 $884,000
Q4 2019

Feb 14, 2020

SELL
$64.27 - $86.37 $3.6 Million - $4.84 Million
-56,000 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$80.14 - $106.07 $1.44 Million - $1.91 Million
-18,000 Reduced 24.32%
56,000 $4.77 Million
Q3 2018

Nov 16, 2018

SELL
$93.92 - $105.72 $3.01 Million - $3.38 Million
-32,000 Reduced 30.19%
74,000 $7.18 Million
Q3 2017

Nov 14, 2017

BUY
$80.6 - $94.95 $8.54 Million - $10.1 Million
106,000
106,000 $9.87 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.